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Introduction
Understanding the causes of long-term disability in multi-
ple sclerosis (MS) is a key goal of current research; it is rel-
evant to how we monitor and treat the disease. Histopathology 
studies show that MS affects brain grey matter (GM), brain 
white matter (WM)1 and the spinal cord.2 However, from 
such work3–5 it is difficult to determine which of these is 
most clinically relevant, and most likely to serve as a useful 
marker of long-term disease progression and treatment 
effectiveness.
Magnetic resonance imaging (MRI), while being less 
pathologically specific, allows us to assess tissue abnor-
malities in vivo and approximate histopathological changes. 
Previous work measuring brain lesion load, brain atrophy 
and spinal cord atrophy demonstrates correlations between 
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Background: Understanding long-term disability in multiple sclerosis (MS) is a key goal of research; it is relevant to 
how we monitor and treat the disease.
Objectives: The Magnetic Imaging in MS (MAGNIMS) collaborative group sought to determine the relationship of brain 
lesion load, and brain and spinal cord atrophy, with physical disability in patients with long-established MS.
Methods: Patients had a magnetic resonance imaging (MRI) scan of their brain and spinal cord, from which we determined 
brain grey (GMF) and white matter (WMF) fractional volumes, upper cervical spinal cord cross-sectional area (UCCA) 
and brain T2-lesion volume (T2LV). We assessed patient disability using the Expanded Disability Status Scale (EDSS). We 
analysed associations between EDSS and MRI measures, using two regression models (dividing cohort by EDSS into two 
and four sub-groups).
Results: In the binary model, UCCA (p < 0.01) and T2LV (p = 0.02) were independently associated with the requirement 
of a walking aid. In the four-category model UCCA (p < 0.01), T2LV (p = 0.02) and GMF (p = 0.04) were independently 
associated with disability.
Conclusions: Long-term physical disability was independently linked with atrophy of the spinal cord and brain T2 lesion 
load, and less consistently, with brain grey matter atrophy. Combinations of spinal cord and brain MRI measures may be 
required to capture clinically-relevant information in people with MS of long disease duration.
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changes in all these regions and the patients’ clinical out-
comes,6–10 albeit of varying strengths in different cohorts 
and with no single measure found to fully explain variabil-
ity in disability. There is increasing interest in the use of 
combinations of MRI measures to more fully characterise 
clinically-relevant pathology in live subjects.
We investigated the relationship of spinal cord and brain 
atrophy, and brain lesion load, with long-term physical dis-
ability (as assessed by the Expanded Disability Status Scale 
(EDSS))11 in a large group of people with MS. In order to 
achieve this, we undertook a multi-centre cross-sectional 
study of patients who had a long history (20 or more years) 
of MS.
Methods
Patients
Seven centres participated in this study, and we included 
patients with relapse-onset (relapsing–remitting (RR) or 
secondary progressive (SP)) MS with their first symptom 
onset 20 or more years prior to their clinical and MRI 
examinations. We classified MS subgroups by Lublin-
Reingold criteria.12 Previous or ongoing disease modifying 
drugs (DMD) were noted.
We determined all patients’ EDSS. The RRMS patients 
who had an EDSS score of ≤ 3 were defined as having 
benign MS.13
Data from patients whom had been treated with steroids 
in the month prior to MRI acquisition were excluded. The 
ethics committee from each of the participating centres 
approved this work and we obtained written informed con-
sent from each subject.
MRI acquisition
MRI scans were acquired using 1.5T (n = 5) or 3T (n = 2) 
scanners and included 3D T1-weighted gradient echo 
sequences of the brain and cervical cord, and dual-echo 2D 
spin-echo sequences of the brain. Our acquisition parame-
ters are summarised in Table 1.
Image analysis
T2 lesion volume. We outlined lesions on T2-weighted 
MRI scans using a semi-automated edge finding tool (JIM 
v. 6.0, Xinapse systems, Aldwincle, UK, http://www.
xinapse.com). The same observer marked all lesions (HK) 
and subsequently, an experienced reader (DC) reviewed 
one in five images. Total lesion volume was recorded in 
mLs for each subject.
Brain tissue volumes. To avoid segmentation errors due to 
WM lesions, we employed an automated lesion-filling 
technique.14 The same observer (HK) created all lesion 
masks based on 3D-T1 weighted sequences only (i.e. with-
out reference to previously created masks on T2-weighted 
images) and an experienced observer (DC) reviewed one 
in five of these images. The lesion-filled images were seg-
mented into WM, GM and cerebrospinal fluid (CSF), 
using the ‘new segment’ option on SPM8 (statistical para-
metric mapping; Wellcome Trust Centre for Neuroimag-
ing, University College London (UCL) Institute of 
Neurology, London). All segmentations were reviewed by 
the same reader (HK), to exclude errors. WM and GM 
fractional (WMF and GMF) volumes, relative to total 
intracranial volume (the sum of GM, WM and CSF vol-
umes), were calculated.
Spinal cord atrophy. Sagittal spinal cord images were refor-
matted axially, into five 3 mm-thick slices perpendicular to 
the long axis of the spinal cord, centred at C2/C3. We eval-
uated the upper cervical cord cross-sectional area (UCCA) 
using an active surface model,15 which has been used in a 
multi-centre study.16 Mean cord area of the five slices was 
determined for each subject.17 The same observer (HK) 
analysed all images.
Statistical analysis
Univariable associations between EDSS and the four MRI 
predictors (WMF, GMF, T2LV, UCCA), and between MRI 
variables, were assessed using Spearman correlation.
For the binary EDSS models (dividing into groups by 
EDSS scores < 6 and ≥ 6, because an EDSS score of 6 
marks the requirement for a walking aid) we performed 
univariable logistic regression followed by multiple logis-
tic regression with the four MRI predictors and centre, age 
at scan, age at onset, disease duration, DMDs and gender, 
initially included as potentially confounding covariates. Of 
these, only centre and age at scan contributed significantly 
(at p < 0.05) or materially affected coefficients, so these 
were subsequently retained in all models. Along with cen-
tre and age at scan, the four MRI predictors were entered 
together and then individually removed from the final mul-
tivariable model, if they did not significantly contribute (at 
p < 0.05). The C-statistic was calculated to assess the pre-
dictive performance of the logistic model; this statistic 
can range from 0.5 (no better than chance) to 1 (perfect 
prediction).
With 4-category EDSS (≤1.5, >1.5 and <3, ≥3 and <6, ≥6; 
categories chosen for even frequency distribution) a similar 
procedure to the above was carried out, using instead pro-
portional odds multiple ordered logistic regression; again, 
centre and age at scan were the only covariates to either be 
significant (at p < 0.05) or materially affect MRI coeffi-
cients, so they were retained in models. The 4-part model 
enabled more complete analysis across the spectrum of dis-
ability, as per previously published work.10
 at University College London on August 4, 2014msj.sagepub.comDownloaded from 
74 Multiple Sclerosis Journal 20(1)
Ta
bl
e 
1.
 M
R
I p
ar
am
et
er
s. C
en
tr
e
Lo
nd
on
Ba
rc
el
on
a
Ba
se
l
M
ila
n 
D
on
 
G
no
cc
hi
M
ila
n 
Sa
n 
R
af
-
fa
el
e
R
om
e
A
m
st
er
da
m
 
Sc
an
ne
r 
br
an
d 
 
(fi
el
d 
st
re
ng
th
)
Ph
ill
ip
s 
(3
T
)
Si
em
en
s 
(1
.5
T
)
Si
em
en
s 
(1
.5
T
)
Si
em
en
s 
(1
.5
T
)
Si
em
en
s 
(1
.5
T
)
G
E 
(1
.5
T
)
G
E 
 (
3T
)
T
2 
br
ai
n 
sc
an
Sl
ic
e 
T
hi
ck
ne
ss
 (
m
m
)
3
3
3
3
5
4
3
 
T
R
 (
m
s)
35
00
25
00
39
80
33
10
38
00
26
20
23
00
 
T
E 
(m
s)
85
91
11
2
11
11
2
11
6
11
4.
1
 
M
at
ri
x 
(m
m
2 )
24
0 
x 
24
0
24
0 
x 
32
0
25
0 
x 
25
6
25
6 
x 
25
6
25
6 
x 
25
6
51
2 
x 
51
2
51
2 
x 
51
2
 
In
 p
la
ne
 r
es
ol
ut
io
n 
(m
m
2 )
1x
1
0.
78
x0
.7
8
0.
98
x0
.9
8
0.
98
x0
.9
8
0.
98
x0
.9
8
0.
63
x0
.6
3
0.
49
x0
.4
9
3D
 T
1 
br
ai
n 
sc
an
Sl
ic
e 
T
hi
ck
ne
ss
 (
m
m
)
1
1.
2
1
1
1.
5
1
1
 
T
R
 (
m
s)
6.
8
23
00
20
80
19
00
20
00
21
7.
8
 
T
E 
(m
s)
3.
1
3
2.
93
3.
4
2.
9
6
3
 
M
at
ri
x 
(m
m
2 )
25
6 
x 
25
6
24
0 
x 
25
6
25
0 
x 
25
6
19
2 
x 
25
6
25
6 
x 
25
6
25
6 
x 
25
6
25
6 
x 
25
6
 
In
 p
la
ne
 r
es
ol
ut
io
n 
(m
m
2 )
1 
x 
1
1 
x 
1
0.
98
 x
 0
.9
8
1 
x 
1
0.
82
 x
 0
.8
2
0.
98
 x
 0
.9
8
0.
94
 x
 0
.9
4
3D
 T
1 
ce
rv
ic
al
 
sp
in
e 
sc
an
    
Sl
ic
e 
T
hi
ck
ne
ss
 (
m
m
)
1
1.
2
1
0.
9
1
1
1
T
R
 (
m
s)
8.
1
23
00
27
00
11
60
11
60
21
7.
2
T
E 
(m
s)
3.
7
3
4.
2
4.
2
4.
2
6
3
M
at
ri
x 
(m
m
2 )
25
6 
x 
25
6
24
0 
x 
25
6
25
6 
x 
25
6
25
6 
x 
51
2
25
6 
x 
25
6
25
6 
x 
25
6
51
2 
x 
51
2
In
 p
la
ne
 r
es
ol
ut
io
n 
(m
m
2 )
1 
x 
1
1 
x 
1
1 
x 
1
0.
45
 x
 0
.4
5
1 
x 
1
0.
98
 x
 0
.9
8
0.
5 
x 
0.
5
3D
: t
hr
ee
-d
im
en
si
on
al
; G
E;
 G
en
er
al
 E
le
ct
ri
c; 
M
R
I: 
m
ag
ne
tic
 r
es
on
an
ce
 im
ag
in
g; 
m
s: 
m
ill
is
ec
on
d;
 T
E:
 e
ch
o 
tim
e;
 T
R
: r
ep
et
iti
on
 t
im
e.
 at University College London on August 4, 2014msj.sagepub.comDownloaded from 
Kearney et al. 75
Differences in means between patient groups were 
assessed by t-test or analysis of variance (ANOVA), for 
comparison of RR and SP, and subgroups of RR with SP. In 
the same way, patients with an EDSS ≤ 3 were compared to 
those with an EDSS ≥ 6, irrespective of disease subtype.
Analyses were carried out using Stata 12 (Stata Corporation, 
College Station, TX, USA) and SPSS 20 (IBM, USA).
Results
Demographics of patients in each participating centre and 
disability category are summarised in Table 2 and Table 3, 
respectively. For the whole group, patients had a mean age 
of 52 years (SD 8.8) with a mean age of disease onset of 
25.8 years (SD 7.7); there were 111 females and 48 males, 
of whom 92 had RRMS and 67 SPMS, with a mean disease 
duration of 26.2 years (SD 6.7) and a median EDSS of 4 
(range 0 – 8). For the 4-category EDSS model, patient num-
bers were as follows: ≤1.5 n=28, >1.5 and <3 n=33, ≥3 and 
<6 n=44, ≥6 n=54.
Brain segmentation failed for four people (we used 155 
volumetric brain scans), two patients did not have a T2W 
scan (we included 157 patients in the T2LV analysis) and 
three patients’ spinal cord scans were distorted, so they 
could not be analysed.
Correlations between MRI features
WMF was significantly correlated with T2LV (r = – 0.21; p 
= 0.01) and UCCA (r = 0.28; p < 0.01). GMF did not cor-
relate significantly with either T2LV or UCCA, but was 
inversely correlated with WMF (r = – 0.26; p < 0.01).
MRI features and clinical subgroups
WMF, T2LV and UCCA were found to differ significantly 
in ANOVA analysis between the RRMS and SPMS groups, 
but no significant difference was found for GMF.
T2LV was significantly higher in SPMS than in benign 
RRMS (EDSS ≤ 3) (mean ± SD = 21.3 ± 14.7 versus 15.7 
± 11.7; p = 0.02), and showed a non-significant trend to be 
higher in SPMS than in the non-benign RRMS group (21.3 
± 14.7 versus 16.1 ± 14.5; p = 0.16). On the other hand, 
T2LV were almost identical in the benign and non-benign 
RRMS groups (15.7 ± 11.7 versus 16.1 ± 14.5; p = 0.94). 
Also, T2LV was found to differ significantly between all 
subjects with EDSS ≥ 6 and those with EDSS ≤ 3 (24.3 ± 
14.4 versus 15.7 ± 11.7; p < 0.01).
UCCA was significantly higher in benign RRMS, when 
compared with both non-benign RRMS (69.7 ± 8.1 versus 
64.8 ± 8.7; p = 0.02) and SPMS (69.7 ± 8.1 versus 64.2 ± 
9.7; p < 0.01). On the other hand, UCCA values were 
almost identical in non-benign RRMS and SPMS sub-
groups (64.8 ± 8.7 versus 64.2 ± 9.7; p = 0.80). UCCA was 
also found to differ significantly between all subjects with 
EDSS ≥ 6 and those with EDSS ≤ 3 (63.3 ± 10.3 versus 
69.7 ± 8.1; p < 0.01). Results of our comparison between 
groups are summarised in Table 4 and Table 5.
MRI features and physical disability (EDSS)
EDSS was significantly correlated with T2LV (Spearman’s 
r = 0.19; p = 0.02), WMF (r = – 0.32; p < 0.01) and UCCA 
(r = – 0.31; p < 0.01), whereas the correlation between 
EDSS and GMF was not significant (r = – 0.07; p = 0.36). 
Scatter plots of MRI variables against EDSS are shown in 
Figure 1.
In a univariable logistic regression analysis for binary 
EDSS groups, we found that both T2LV (odds ratio (OR) = 
1.98 per 1 SD larger T2LV; 95% CI 1.39, 2.82; p < 0.01) 
and UCCA (OR = 0.55 per 1 SD higher cord area; 95% CI 
0.38, 0.79; p < 0.01) were associated with EDSS ≥ 6. In a 
univariable ordered logistic regression for 4-category 
EDSS, we found the following associated with EDSS: 
T2LV (OR = 1.56 per 1 SD larger T2LV; 95% CI 1.16, 2.10; 
p < 0.01), UCCA (OR = 0.53 per 1 SD higher cord area; 
95% CI 0.39, 0.72; p < 0.01) and WMF (OR = 0.62 per 1 
SD WMF; 95% CI 0.47, 0.82; p < 0.01).
We subsequently performed a multivariable analysis, 
again using a binary and then 4-part model of EDSS. Both 
T2LV (OR = 1.67 per 1 SD larger T2LV; 95% CI 1.09, 2.56; 
p = 0.02) and UCCA (OR = 0.57 per 1 SD higher cord area; 
95% CI 0.37, 0.86; p = 0.01) were found to be associated 
independently with the requirement of a walking aid (i.e. 
EDSS ≥ 6). The C-statistic for this model was 0.8, with 
81% sensitivity and 75% specificity, and 77% correctly 
classified. In a multivariable ordered logistic regression 
model with a 4-part model of EDSS, the following were 
found to be associated with EDSS: UCCA (OR = 0.55 per 
1 SD higher cord area; 95% CI 0.40, 0.77; p < 0.01), T2LV 
(OR = 1.56 per 1 SD larger T2LV; 95% CI 1.08, 2.25; p = 
0.02) and GMF (OR = 0.67 per 1 SD GMF; 95% CI 0.46, 
0.98; p = 0.04).
Discussion
In this work we studied a large group of MS patients, two to 
three decades after their first symptom onset. Our results 
show that UCCA, T2LV and less consistently, brain GM 
atrophy independently associated with EDSS.
When considering the results, it should be noted that this 
cohort differs from previous studies looking simultaneously 
at spinal cord and brain measures in MS.6,8 Firstly, the pre-
sent cohort is larger, with 159 patients, compared with the 70 
studied by Bonati et al. and 21 by Cohen et al. Secondly, it 
includes patients with longer disease duration (mean of 26 
years, as compared to 20 years and 8 years, respectively). 
Thirdly, it includes more people with higher levels of disabil-
ity (median EDSS current study=4; Bonati et al. median=2.5; 
Cohen et al. mean=1.6) and more SPMS patients (current 
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study, n=67; Bonati et al., n=11; Cohen et al., n=1); however 
(unlike the previous two studies), this is a multicentre study, 
and so differences in scanners can introduce inter-site varia-
bility.18 The statistical analyses adjusted for centre effects, so 
we are confident the findings are real.
Overall, our findings agree with previous studies6,8 dem-
onstrating that UCCA is independently related to disability. 
With regard to changes in the brain, Cohen et al. find no 
additional association with disability in a group of mostly 
RRMS patients with low EDSS scores, while in a mixed 
CIS, RRMS and SPMS cohort with long disease duration, 
Bonati et al. observe that GMF independently associates 
with EDSS in all cases, and T2LV in those cases with clini-
cally definite MS. In the present cohort, T2LV; and in the 
4-part EDSS model only, GMF were found to contribute to 
variability in EDSS. The consistent, independent relation-
ship of UCCA with disability in all three studies of cohorts 
with RRMS and SPMS, with disease durations ranging 
from a mean of 8 – 26 years, is noteworthy. An association 
of disability with T2LV and GM atrophy, independent of 
spinal cord atrophy, was only evident in the 20- and 26-year 
disease duration cohorts, suggesting that the effects of brain 
GM pathology in MS may become more relevant with 
longer disease duration.
Given that it can be difficult to determine the onset of pro-
gressive MS, and as a natural history study suggests SPMS 
tends to occur at a similar rate when a disability threshold is 
reached, rather than being determined by prior relapses,19 it 
was of interest to see if there were MRI differences between 
benign and non-benign RRMS, and non-benign RRMS and 
SPMS. In order to do this, we split the RRMS cohort into 
‘benign’ (i.e. EDSS ≤ 3) and those with an EDSS of ≥ 3.5. In 
doing so, we were aware that this division is defined by phys-
ical disability and that cognitive deficits may be considerable 
in people with physically ‘benign’ MS.20 No significant dif-
ferences emerged between T2LV brain or spinal cord atrophy, 
between the non-benign RRMS and SPMS patients. This sug-
gested that the division between these groups on the basis of 
clinical progression may be arbitrary and not strongly sup-
ported by differences in MRI characteristics.
Lower UCCA values were evident in both SPMS and 
non-benign RRMS, when compared with benign MS, thus 
UCCA seemed to relate to concurrent physical disability. In 
this study, we used EDSS as a measure of disability, 
although it does not fully reflect the clinical impact of MS. 
Above 3.5, the EDSS is heavily weighted towards mobility; 
and thus, corticospinal tract integrity. In turn, those MRI 
measures that were more directly linked with the corti-
cospinal tracts were more likely to correlate with EDSS, 
hence the association between UCCA and disability 
emerged consistently in all models. This study builds on 
previous work, demonstrating that UCCA is relevant to 
physical disability in MS, and that this relationship remains 
significant in the long-term, in people with higher EDSS, 
and in both RR and SPMS.
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A question arising from our observation that the highest 
T2LV was seen in SPMS is whether a high T2LV in earlier 
years might predict future secondary progression? Although 
our cross-sectional study could not directly investigate this, 
evidence from two other studies supports a long-term prog-
nostic role of T2LV in relapse-onset MS. First, a 20-year 
follow up of a CIS cohort found that the rate of increase of 
T2LV was three times higher in those that develop SPMS, 
compared to those patients who remained RRMS; and that 
the higher T2LV was already evident after 5 years, in those 
who later developed SPMS.9 Secondly, in a recent 21-year 
follow-up study that reported mortality outcomes of RRMS 
patients who had participated in a clinical trial of beta 
interferon, Goodin et al. finds that the baseline T2LV is an 
Table 3. Patient demographics by EDSS category.
RRMS (EDSS ≤ 3) RRMS (EDSS ≥ 3.5) SPMS
n 70 22 67
Age (years) mean ± SD 49.5 ± 8.1 49.7 ± 7.5 55.4 ± 8.7
Gender (female, male) 49, 21 20, 2 42, 25
Disease duration mean ± SD 25.2 ± 0.5 26.1 ± 4.1 27.3 ± 7.8
EDSS: Expanded Disability Status Scale; RRMS: relapsing–remitting multiple sclerosis; SPMS: secondary progressive multiple sclerosis.
Table 4. MRI parameters in benign and ‘non-benign’ RRMS and SPMS.
All RRMS Benign RRMS Non-Benign RRMS SPMS
T2LV (mL) Mean 16.0 15.7 16.1 21.3
 SD 12.3 11.7 14.5 14.7
UCCA (mm2) Mean 68.6 69.7 64.8 64.2
 SD 8.4 8.1 8.7 9.7
WMF Mean 0.332 0.335 0.324 0.324
 SD 0.019 0.018 0.021 0.017
GMF Mean 0.460 0.462 0.457 0.460
 SD 0.014 0.014 0.012 0.014
GMF: grey matter fractional volume; MRI: magnetic resonance imaging; RRMS: relapsing–remitting multiple sclerosis; SPMS: secondary progressive 
multiple sclerosis; T2LV: lesion volume upon T2-weighted MRI scanning; UCCA: upper cervical cord cross-sectional area; WMF: white matter fractional 
volume.
Table 5. Comparison of MRI parameters between benign and ‘non-benign’ RRMS and SPMS using ANOVA.
MS subtypes being compared p value
T2LV (mL) Benign RRMS/Non-Benign RRMS 0.94
 Benign RRMS/SPMS 0.02
 Non-Benign RRMS/SPMS 0.16
 All RRMS/SPMS 0.02
UCCA (mm2) Benign RRMS/Non-Benign RRMS 0.02
 Benign RRMS/SPMS < 0.01
 Non-Benign RRMS/SPMS 0.80
 All RRMS/SPMS < 0.01
WMF Benign RRMS/Non-Benign RRMS 0.02
 Benign RRMS/SPMS < 0.01
 Non-Benign RRMS/SPMS 0.98
 All RRMS/SPMS 0.01
GMF Benign RRMS/Non-Benign RRMS 0.24
 Benign RRMS/SPMS 0.55
 Non-Benign RRMS/SPMS 0.47
 All RRMS/SPMS 0.81
ANOVA: Analysis of variation; GMF: grey matter fractional volume; MRI: magnetic resonance imaging; MS: multiple sclerosis; RRMS: relapsing–remitting 
multiple sclerosis; SPMS: secondary progressive multiple sclerosis; T2LV: lesion volume upon T2-weighted MRI scanning; UCCA: upper cervical cord 
cross-sectional area; WMF: white matter fractional volume.
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independent predictor of death.21 Although no information 
on neurological status was provided in that study, it is plau-
sible that the higher mortality reflects a greater likelihood 
of patients with high lesion loads to develop secondary pro-
gression with severe disability.
In the current study’s univariable analyses, WMF was 
associated with EDSS, but not in the multivariable analysis, 
where GMF was independently associated. This can be 
explained by the inter-relationships between MRI meas-
ures. For a MRI measure to be retained in a regression 
model, it must correlate with the outcome of interest and do 
so at least partly independently of other measures. WMF 
was significantly correlated with both T2LV and UCCA, 
whereas GMF was not, and when both T2LV and UCCA 
were included in the statistical multivariable model, WMF 
did not add to the predictive power of the model above that 
of T2LV and UCCA alone. In contrast, while GMF alone 
did not correlate with clinical measures in univariate analy-
sis, once variability due to T2LV and UCCA had been 
accounted for, it did contribute independently to disability 
in the 4-part model of EDSS, albeit with modest signifi-
cance (p = 0.04). Although we found a negative correlation 
between GMF and WMF, this very likely represented a 
mathematical interaction between the two fractional vol-
umes that have a common denominator, rather than an error 
in segmentation: when the actual GM and WM volumes 
were compared without normalisation, we saw a strong 
positive correlation, as expected (data not shown).
As a conceptual limitation of our study, it cannot be 
assumed the same associations would be observed if differ-
ent outcome measures were used. Cognitive impairment 
is common in MS, particularly in SPMS,22,23 and if the 
Figure 1. Graphs of T2LV (a), SCA (b), GMF (c), WMF (d) against EDSS.
EDSS: expanded disability status scale; GMF: grey matter fractional volume; SCA: spinal cord area;  T2LV: lesions seen upon T2 MRI imaging;   
WMF: white matter fractional volume.
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cognitive scores were used instead, the imaging associa-
tions may differ. A previous longitudinal study in SPMS 
demonstrates a significant correlation of reductions in GM 
volume, but not UCCA or T2LV, with paced auditory serial 
addition test (PASAT) scores.24
Although GMF was associated independently with EDSS in 
the 4-part model, no significant differences were established 
between GMF in RRMS and SPMS cohorts, although we 
observed a weak trend between lower GMF values with higher 
EDSS scores. A stronger correlation between EDSS and GMF 
was observed in a previous study of a MS cohort with a 20-year 
disease duration.10 Several factors may have limited the associa-
tions observed in the present study. First, many subjects had large 
lesion loads, which could have had subtle effects on brain seg-
mentation, in spite of using lesion filling to correct tissue vol-
umes.14 Secondly, lesions partly involving the deep GM may still 
sometimes have been classified as WM, leading to slight inac-
curacies of WMF and GMF computation. Thirdly, there was 
often substantial atrophy. The GM and WM segmentation algo-
rithm that we used (SPM) was developed from a normal (non-
atrophic) brain template, and its performance may differ in the 
presence of marked brain atrophy. Finally, the cohort studied had 
a disease duration that considerably exceeded that of other 
cohorts in whom associations were observed between GM atro-
phy and disability.7,10 It is possible that GM atrophy may reach a 
nadir at a later point in the natural history of the disease, beyond 
which it has a lesser independent contribution to disability.
Two other study limitations are noted. First, this study was 
cross-sectional, and although T2LV, UCCA, and to a lesser 
extent GMF, were found to be independently associated with 
concurrent disability, the rate of change of these measures 
over time was not examined. Longitudinal observations 
would be required to clarify their temporal dynamics, in rela-
tionship to changes in disability measures.
Secondly, this was a multi-centre study. This allowed a 
larger cohort to be studied, but that will have introduced 
some variability in MRI measures, and while these were 
accounted for in the statistical models, they may still have 
influenced the apparent strength of associations between 
MRI measures and clinical scores.
This study showed that spinal cord and brain pathology 
are both relevant, contributing independently to long-term 
physical disability in relapse-onset MS. The results also 
highlighted that combinations of MRI measures may be 
required to optimally capture clinically-relevant informa-
tion in people with MS of long disease duration.
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